USAID Pings Old FOIA Requesters: Still Interested?
Published Date: 9/16/2025
Notice
Summary
USAID wants to check if people who asked for information before January 20, 2025, are still interested in their requests. This helps USAID work faster, save resources, and clear backlogs. If you made a request, expect a quick check-in to keep things moving smoothly—no extra cost or wait time for you!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
USAID 'Still Interested' FOIA Checks
If you submitted a Freedom of Information Act (FOIA) request to USAID before January 20, 2025, USAID will contact you to confirm whether you are still interested in having your request processed. USAID says it will do this check before continuing processing to increase efficiency, allocate resources, and reduce its FOIA backlog.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10817, Regulation for Federal Financial Assistance
This new rule updates how federal financial help is given and managed across many government agencies. It affects anyone who gets federal grants or aid, making the process clearer, fairer, and easier to follow. Changes kick in soon and could impact how money flows and how quickly folks get support.
2025-01335, Agency Information Collection Activities; 2025 Digital Development Awards Application
USAID is launching a new survey to pick winners for the 2025 Digital Development Awards, celebrating projects that use digital tech to boost growth and help communities. Anyone interested can review the survey and send comments by February 24, 2025. This is a great chance for digital innovators to shine and get recognized for their impact!
2026-22842, Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h)
The DEA is boosting the 2026 production limits for four important medicines: d,l-amphetamine, d-amphetamine (for sale), hydromorphone, and methylphenidate (for sale). This change helps fix shortages and keeps medicines flowing smoothly. The new quotas take effect right away on November 10, 2026, so manufacturers can ramp up production without delay.
2026-22838, Notice of Intent To Reorganize HUD and Revise Headquarters and Field Operating Model
HUD is shaking things up to work smarter, not harder! They’re reorganizing how their headquarters and field offices operate to cut down on extra steps, boost flexibility, and save money—all without closing offices or moving staff. These changes will roll out after a 90-day review, aiming to help HUD serve you better using the resources they already have.
2026-22840, Notice of Removal of Designated Chinese Military Company
The Department of Defense has officially removed WuXi AppTec from the list of Chinese military companies operating in the U.S. This change follows a court order and means WuXi AppTec is no longer restricted under this designation—at least for now. Businesses and investors can expect updated rules starting immediately, but the company could be added back later if new reasons arise.
2026-22843, Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
The DEA is setting limits on how much of certain controlled drugs and chemicals can be made in 2027. This affects drug makers and anyone involved in producing or handling these substances. They’re asking for public comments by December 10, 2026, before finalizing the amounts, which helps keep drug supply safe and balanced.
Previous / Next Documents
Previous: 2025-17819, Importer of Controlled Substances Application: Catalent Greenville, Inc.
Catalent Greenville, Inc. wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that need special handling. If approved, it could affect companies and regulators watching drug imports, with no immediate cost or deadline changes announced.
Next: 2025-17821, Meeting of the Advisory Committee on Immunization Practices; Amended Notice of Meeting
The CDC just updated the meeting details for the Advisory Committee on Immunization Practices (ACIP), which helps decide vaccine guidelines. This change affects healthcare pros and the public who follow vaccine news. The meeting is still open to everyone, so mark your calendars and stay tuned for important vaccine updates that could impact health decisions and budgets.